Macter International Limited (PSX:MACTER)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
343.08
-6.71 (-1.92%)
At close: Feb 13, 2026
Market Cap15.72B +22.8%
Revenue (ttm)10.96B +29.2%
Net Income834.71M +77.9%
EPS18.22 +78.3%
Shares Out45.81M
PE Ratio18.83
Forward PEn/a
Dividend3.80 (1.11%)
Ex-Dividend DateOct 16, 2025
Volume19,667
Average Volume50,335
Open347.01
Previous Close349.79
Day's Range336.00 - 350.00
52-Week Range248.00 - 621.82
Beta0.12
RSI52.40
Earnings DateFeb 14, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1992
Employees 1,282
Stock Exchange Pakistan Stock Exchange
Ticker Symbol MACTER
Full Company Profile

Financial Performance

In fiscal year 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.

Financial Statements